Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period

Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period

PurposeTo investigate the clinical predictors of in-hospital mortality in hospitalized patients with Coronavirus disease 2019 (COVID-19) infection during the Omicron period.MethodsAll consecutive hospitalized laboratory‐confirmed COVID-19 patients between January and May 2022 were retrospectively an...

Full description

Bibliographic Details
Main Authors: Andrea Sonaglioni, Michele Lombardo, Adriana Albini, Douglas M. Noonan, Margherita Re, Roberto Cassandro, Davide Elia, Antonella Caminati, Gian Luigi Nicolosi, Sergio Harari
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
Charlson comobidity index
neutrophil-to-lymphocyte ratio
angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers
mortality
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.958418/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.958418/full

Similar Items